We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Visual Recognition System Supports Malaria Diagnostics

By LabMedica International staff writers
Posted on 03 Sep 2014
Print article
Image: Tablet computer used for visualization of diagnostically relevant RBCs. (Photo courtesy of Ari Hallami / FIMM).
Image: Tablet computer used for visualization of diagnostically relevant RBCs. (Photo courtesy of Ari Hallami / FIMM).
An innovative system uses computer vision algorithms, similar to those used in facial recognition systems, to provide a decision support system for diagnosing malaria infection.

Developed by researchers at the Finnish Institute for Molecular Medicine (FIMM; Helsinki), the University of Helsinki (Finland), and Karolinska institutet (Stockholm, Sweden), the "man and machine" diagnostic aid digitizes and analyzes more than 50,000 red blood cells (RBCs) per blood sample, ranking them according to the probability of infection. The program then creates a panel containing images of more than a hundred most likely infected RBCs, and presents that panel to the user. Final diagnosis is by a health-care professional, based on the visualized images.

During the testing phase, more than 90% of the infected samples were accurately diagnosed based on the panel. The few problematic samples were of low quality, and in a true diagnostic setting would have led to further analyses. When comparing the system to existing diagnosed samples, the researchers were able to show that the accuracy of the computer vision algorithms was comparable to the quality criteria defined by the World Health Organization (WHO; Geneva, Switzerland). The study describing the system and its testing was published on August 21, 2014, in PLOS One.

“The equipment needed for digitization of the samples is a challenge in developed countries. In the next phase of our project we will test the system in combination with inexpensive mobile microscopy devices that our group has also developed,” said lead author Nina Linder, MD, PhD, of FIMM. “There is also a strong need for fast and accurate methods for measuring the malaria parasite load in a sample. Various malaria drug screening programs are underway and the parasite load in a large number of samples needs to be quantified for determining the efficacy of potential drugs. We are further developing the computer algorithms used in this study to meet this need as well.”

According to the researchers, the developed support system could be applied in various other fields of medicine. In addition to other infectious diseases such as tuberculosis (TB), the research group is planning to test the system for cancer diagnostics in tissue samples.

There are more than 200 million new malaria cases yearly, and high-quality microscopy is still the most accurate method for detection of infection. Microscopy, however, can be very time-consuming, placing a heavy workload on trained health-care personnel, thus contributing to the demonstrably low accuracy of microscopy. As a result, less than half of the suspected malaria cases in Sub-Saharan Africa in 2012 received a diagnostic test.

Related Links:

Institute for Molecular Medicine Finland
University of Helsinki
Karolinska institutet


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more

Pathology

view channel
Image: The new AI tool can help beat brain tumors (Photo courtesy of Crystal Light/Shutterstock)

New AI Tool Classifies Brain Tumors More Quickly and Accurately

Precision in diagnosing and categorizing tumors is essential for delivering effective treatment to patients. Currently, the gold standard for identifying various types of brain tumors involves DNA methylation-based... Read more